Literature DB >> 27130614

Endometriosis-related infertility: ovarian endometrioma per se is not associated with presentation for infertility.

P Santulli1, M C Lamau2, L Marcellin3, V Gayet2, P Marzouk2, B Borghese4, Marie-Christine Lafay Pillet2, C Chapron5.   

Abstract

STUDY QUESTION: Is there an association between the endometriosis phenotype and presentation with infertility? SUMMARY ANSWER: In a population of operated patients with histologically proven endometriosis, ovarian endometrioma (OMA) per se is not associated with an increased risk of presentation with infertility, while previous surgery for endometriosis was identified as a risk factor for infertility. WHAT IS KNOWN ALREADY: The increased prevalence of endometriosis among subfertile women indicates that endometriosis impairs reproduction for reasons that are not completely understood. STUDY DESIGN, SIZE, DURATION: This was an observational, cross-sectional study using data prospectively collected in all non-pregnant patients aged between 18 and 42 years, who were surgically explored for benign gynaecological conditions at our institution between January 2004 and March 2013. For each patient, a standardized questionnaire was completed during a face-to-face interview conducted by the surgeon during the month preceding surgery. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Surgery was performed in 2208 patients, of which 2066 signed their informed consent. Of the 1059 women with a visual diagnosis of endometriosis, 870 had histologically proven endometriosis and complete treatment for their endometriotic lesions, including 307 who presented with infertility. Univariate analysis and multiple logistic regression analysis were performed to determine factors associated with infertility. MAIN RESULTS AND THE ROLE OF CHANCE: The following variables were identified as risk factors for endometriosis-related infertility: age >32 years (odds ratio [OR] = 1.9; 95% confidence interval [CI]: 1.4-2.4), previous surgery for endometriosis (OR = 1.9; 95% CI: 1.3-2.2), as well as peritoneal superficial endometriosis (OR = 3.1; 95% CI: 1.9-4.9); Conversely, previous pregnancy was associated with a lower rate of infertility (OR = 0.7; 95% CI: 0.6-0.9 and OR = 0.6; 95% CI: 0.4-0.9, respectively). OMA is not selected as a significant risk factor for infertility. LIMITATIONS, REASON FOR CAUTION: The selection of our study population was based on a surgical diagnosis. We cannot exclude that infertile women with OMA associated with a diminished ovarian reserve, as assessed during their infertility work-up, were referred less frequently to surgery and might therefore be underrepresented. In addition we cannot exclude that our group of infertile women present associated other causes of infertility. WIDER IMPLICATIONS OF THE
FINDINGS: Identification of risk and preventive factors of endometriosis-related infertility can help improve clinical and surgical management of endometriosis in the setting of infertility. STUDY FUNDING/COMPETING INTERESTS: None. TRIAL REGISTRATION NUMBER: None.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  endometrioma management; endometriosis; female infertility; ovarian endometrioma; previous history of surgery; risk factor

Mesh:

Year:  2016        PMID: 27130614     DOI: 10.1093/humrep/dew093

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms.

Authors:  Emily De Conto; Úrsula Matte; João Paolo Bilibio; Vanessa Krebs Genro; Carlos Augusto Souza; Delva Pereira Leão; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2017-08-22       Impact factor: 3.412

2.  Factors associated with a poor prognosis for the IVF-ICSI live birth rate in women with rAFS stage III and IV endometriosis.

Authors:  Pauline Roux; Jeanne Perrin; Julien Mancini; Aubert Agostini; Léon Boubli; Blandine Courbiere
Journal:  J Assist Reprod Genet       Date:  2017-05-18       Impact factor: 3.412

3.  Does Dysmenorrhea Affect Clinical Features and Long-Term Surgical Outcomes of Patients With Ovarian Endometriosis? A 12-Year Retrospective Observational Cohort Study.

Authors:  Yushi Wu; Xiaoyan Li; Yi Dai; Jinghua Shi; Zhiyue Gu; Jing Zhang; Chenyu Zhang; Hailan Yan; Jinhua Leng
Journal:  Front Med (Lausanne)       Date:  2022-06-16

4.  Iron-overloaded follicular fluid increases the risk of endometriosis-related infertility by triggering granulosa cell ferroptosis and oocyte dysmaturity.

Authors:  Zhexin Ni; Yangshuo Li; Di Song; Jie Ding; Shanshan Mei; Shuai Sun; Wen Cheng; Jin Yu; Ling Zhou; Yanping Kuang; Mingqing Li; Zailong Cai; Chaoqin Yu
Journal:  Cell Death Dis       Date:  2022-07-04       Impact factor: 9.685

5.  Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.

Authors:  Yaoqiu Wu; Rong Yang; Jie Lan; Haiyan Lin; Xuedan Jiao; Qingxue Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-22       Impact factor: 5.555

Review 6.  Epigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility.

Authors:  Magdalena Adamczyk; Ewa Wender-Ozegowska; Malgorzata Kedzia
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

7.  Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.

Authors:  Anji Li; Jie Zhang; Yanping Kuang; Chaoqin Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

Review 8.  Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies.

Authors:  Yi-Heng Lin; Ya-Hsin Chen; Heng-Yu Chang; Heng-Kien Au; Chii-Ruey Tzeng; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2018-08-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.